FOXD1 and nonpapillary renal cell carcinoma: A more tractable strategy is to modulate pathways regulated by FOXD1, and in this study we used a transcriptomic analysis to identify specific pathways downstream from FOXD1 that can be pharmacologically modulated to suppress the G2/M transition in ccRCC tumor cells.